Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder

These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipolar disorder.

News

Dr. Joan Comella is appointed treasurer of ICORD, a world reference organization in rare diseases

Dr. Mireia del Toro, PI of the Pediatric Neurology group and President of the Rare Diseases Commission of the Vall d'Hebron University Hospital joins the board.

News

Vall d'Hebron begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis

Seraph 100 consists of a filter capable of binding and eliminating microorganisms in the blood of patients who have an infection. The clinical trials that are now underway will study whether this system can reduce the severity of critical patients with COVID-19 and sepsis.

News

A study in Vall d’Hebron links feather-filled bedding to the appearance of lung problems

A study in Vall d’Hebron links feather-filled bedding to the appearance of lung problems

News

HIPOFAM makes a donation of € 15,000 to the VHIR and reaches more than € 140,000 raised since 2015

HIPOFAM makes a donation of € 15,000 to the VHIR and reaches more than € 140,000 raised since 2015

News

An international study involving Vall d’Hebron shows that COVID-19 increases the risk of complications during pregnancy

The INTERCOVID project finds that infected women are 50% more likely to have complications during pregnancy.

News

Vall d’Hebron celebra Sant Jordi amb roses solidàries i missatges amb cor per a les persones ingressades i roses per al personal del Campus

Cada persona ingressada rebrà una "rosa amb cor" solidària, un llibre i un missatge de felicitació o ànims escrit per un o una professional, entre d'altres obsequis, i es regalaran roses al personal sanitari.

News

Vall d'Hebron participates in the CombivacS clinical trial that will evaluate a second dose of the Pfizer vaccine to people already vaccinated with a dose of AstraZeneca

The trial aims to provide scientific evidence to support decision-making regarding a possible alternative to complete immunization in people under 60 vaccinated with a dose of AstraZeneca.

News

A pioneering study by Vall d'Hebron demonstrates the efficacy of a new recovery protocol for patients with advanced ovarian cancer

The Enhanced Recovery After Surgery (ERAS) protocol allows patients undergoing surgery for advanced ovarian cancer to be discharged from hospital up to 2 days earlier and decrease their readmission rate.

News

The VHIR develops a research project to reduce child mortality in Angola

The VHIR develops a research project to reduce child mortality in Angola

News

The ALUDME association donates €16,000 to the MoutePerLaDistonia campaign in Vall d’Hebron

The proceeds will go to a project to study dystonia and establish new treatments to improve patient care.

News

Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19

14 health professionals and researchers are speakers or moderators of round tables to analyze the impact of COVID-19 from different perspectives.

News

Dra. Patricia Pozo Rosich participates in a series of articles on migraine published in The Lancet

The publications review the socioeconomic impact of migraine and the diagnostic and therapeutic advances in this field.

News

#RosesAmbCor, la campanya doblement solidària que protagonitzarà el Sant Jordi d’enguany

La iniciativa repartirà roses entre tots els pacients ingressats a Vall d'Hebron el dia 23 d'abril perquè tots ells i elles puguin gaudir del Sant Jordi encara que no puguin celebrar-lo al carrer.

News

Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder

The PORTICO study will evaluate the efficacy and safety of vafidemstat in Borderline Personality Disorder patients.

News

Red Transfronteriza de interpretación del cribado neonatal: de la mutación al paciente (EFA 086/15)

Pirepred integrará a los hospitales que encargan o realizan pruebas de diagnóstico genético relacionadas con los programas de cribado neonatal, para definir sus necesidades comunes y hacer recomendaciones para mejorar su gestión

News

Self-injurious behaviors are among the main reasons why children and adolescents consult in mental health emergency room

Researchers have analyzed 566 clinical episodes related to mental health problems that they attended in the Pediatric Emergency Room of Vall d'Hebron from 2015 to 2017.

News

Three professionals from Vall d'Hebron, winners of the Spanish Society of Neurology Awards

The SEN Awards 2019 recognize the contribution of Dr. Jorge Pagola, Dr. Miquel Vila and Dr. Patricia-Pozo Rosich in the field of neurological diseases.

News

Caprabo will allocate the money raised in April from the solidarity penny program to Parkinson's research

Vall d'Hebron starts a campaign in collaboration with Caprabo, with the aim of raising funds for the Vall d'Hebron Parkinson Initiative (VHIP) research project, aimed at early detection of the disease.

News

Josep Baselga, former head of Medical Oncology at Vall d'Hebron and first director of the VHIO, dies at 61

Dr. Baselga, internationally renowned medical oncologist from Barcelona, former head of Medical Oncology at Vall d'Hebron and first director of the Vall d'Hebron Institute of Oncology, has died at the age of 61.